Literature DB >> 10516670

Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.

K Terata1, L J Coppey, E P Davidson, J A Dunlap, D D Gutterman, M A Yorek.   

Abstract

1. Diabetes mellitus produces marked abnormalities in motor nerve conduction, but the mechanism is not clear. In the present study we hypothesized that in the streptozotocin (STZ)-induced diabetic rat impaired vasodilator function is associated with reduced endoneural blood flow (EBF) which may contribute to nerve dysfunction. 2. We examined whether diabetes-induced reductions in sciatic nerve conduction velocity and EBF were associated with impaired endothelium-dependent dilation in adjacent arterioles. We measured motor nerve conduction velocity (MNCV) in the sciatic nerve using a non-invasive procedure, and sciatic nerve nutritive blood flow using microelectrode polarography and hydrogen clearance. In vitro videomicroscopy was used to quantify arteriolar diameter responses to dilator agonists in arterioles overlying the sciatic nerve. 3. MNCV and EBF in 4-week-STZ-induced diabetic rats were decreased by 22% and 49% respectively. Arterioles were constricted with U46619 and dilation to acetylcholine (ACh), aprikalim, or sodium nitroprusside (SNP) examined. All agonists elicited dose-dependent dilation in control and diabetic rats, although ACh-induced dilation was significantly reduced in diabetic rats. Treating vessels from normal or diabetic rats with indomethacin (INDO) alone did not significantly affect ACh-induced relaxation. However, ACh-induced vasodilation was significantly reduced by treatment with KCl or Nomega-nitro-L-arginine (LNNA) alone. Combining LNNA and KCl further reduced ACh-induced dilation in these vessels. 4. Diabetes causes vasodilator dysfunction in a microvascular bed that provides circulation to the sciatic nerve. These studies imply that ACh-induced dilation in these vessels is mediated by multiple mechanisms that may include the endothelial-dependent production of nitric oxide and endothelial-derived hyperpolarizing factor. This impaired vascular response is associated with neural dysfunction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516670      PMCID: PMC1571695          DOI: 10.1038/sj.bjp.0702856

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Impairment of endothelium-dependent but not of endothelium-independent dilatation in guinea-pig aorta rings incubated in the presence of elevated glucose.

Authors:  P Dorigo; D Fraccarollo; G Santostasi; I Maragno
Journal:  Br J Pharmacol       Date:  1997-07       Impact factor: 8.739

2.  Increased sciatic nerve blood flow in diabetic rats: assessment by "molecular" vs. particulate microspheres.

Authors:  K Chang; Y Ido; W LeJeune; J R Williamson; R G Tilton
Journal:  Am J Physiol       Date:  1997-07

Review 3.  Diabetic vascular complications.

Authors:  M E Cooper; R E Gilbert; G Jerums
Journal:  Clin Exp Pharmacol Physiol       Date:  1997 Sep-Oct       Impact factor: 2.557

Review 4.  Hyperpolarizing factors.

Authors:  J Quilley; D Fulton; J C McGiff
Journal:  Biochem Pharmacol       Date:  1997-11-15       Impact factor: 5.858

5.  Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats.

Authors:  L Rodríguez-Mañas; J Angulo; C Peiró; J L Llergo; A Sánchez-Ferrer; P López-Dóriga; C F Sánchez-Ferrer
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

6.  Flow-induced dilatation in isolated resistance arteries from control and streptozotocin-diabetic rats.

Authors:  R M Tribe; C R Thomas; L Poston
Journal:  Diabetologia       Date:  1998-01       Impact factor: 10.122

7.  Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve.

Authors:  D A Greene; S A Lattimer
Journal:  Am J Physiol       Date:  1984-04

8.  Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Authors:  K R Gillon; J N Hawthorne; D R Tomlinson
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

9.  Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat.

Authors:  D A Greene; S Yagihashi; S A Lattimer; A A Sima
Journal:  Am J Physiol       Date:  1984-10

Review 10.  H2 clearance measurement of blood flow: a review of technique and polarographic principles.

Authors:  W Young
Journal:  Stroke       Date:  1980 Sep-Oct       Impact factor: 7.914

View more
  17 in total

1.  Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.

Authors:  Eric P Davidson; Lawrence J Coppey; Nigel A Calcutt; Christine L Oltman; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2010-05       Impact factor: 4.876

2.  Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat.

Authors:  Eric P Davidson; Lawrence J Coppey; Amey Holmes; Mark A Yorek
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.

Authors:  Christine L Oltman; Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Brian Dake; Mark A Yorek
Journal:  Eur J Pharmacol       Date:  2010-10-30       Impact factor: 4.432

4.  The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.

Authors:  Eric Davidson; Lawrence Coppey; Bao Lu; Victor Arballo; Nigel A Calcutt; Craig Gerard; Mark Yorek
Journal:  Exp Diabetes Res       Date:  2010-02-03

5.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.

Authors:  X L Du; D Edelstein; S Dimmeler; Q Ju; C Sui; M Brownlee
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

6.  Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment.

Authors:  Eric P Davidson; Lawrence J Coppey; Mark A Yorek
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-07       Impact factor: 4.799

7.  Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.

Authors:  L J Coppey; J S Gellett; E P Davidson; J A Dunlap; D D Lund; D Salvemini; M A Yorek
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

8.  NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy.

Authors:  Kirsten Thomsen; Inger Rubin; Martin Lauritzen
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

9.  Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.

Authors:  C L Oltman; E P Davidson; L J Coppey; T L Kleinschmidt; M A Yorek
Journal:  Diabetes Obes Metab       Date:  2008-06-16       Impact factor: 6.577

Review 10.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.